Question for BDAZ, Re: BETonMACE Enrollment
in response to
by
posted on
Jun 28, 2017 02:56PM
ATTENTION MEMBERS:
Tonight, we're giving our website a serious makeover.
So if you can't access the site for a bit, don't worry, we're just sprucing things up for an even smoother experience.
In the event that you experience issues accessing the new site, please clear your browser's cookies and cache.
See You On The Other Side!
I don't know why I didn't think of this before but it seems to me that when we are talking about the timing of the Futility Analysis we are assuming that the test arm will have a relatively uniform response. To me it would seem possible that the test arm could have two distinctly different subsets, as in ASSURE. Since one group in the test arm is on Apabetalone + atorvastatin and the other is on Apabetalone + rosuvastatin it would seem that there is more room for various outcomes and thus influence the timing of reaching 125 events. Bear do you think this is valid logic?